2017 Fiscal Year Final Research Report
Development of a ganma-tubulin targeting diketopiperazine and its study on chemical biology
| Project/Area Number |
16K15145
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Drug development chemistry
|
|---|
| Research Institution | Tokyo University of Pharmacy and Life Science |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Keywords | ジケトピペラジン / γ-チューブリン / プリナブリン / 抗がん剤 / 水溶性プロドラック |
|---|
| Outline of Final Research Achievements |
In this study we focus on a novel diketopiperazine (DKP) derivative "KPU-406" targeting γ-tubulin. To elucidate the function of γ-tubulin, a potential target molecule for cancer therapy, we synthesized fragment derivatives having a partial structure of KPU-406 and biotinylated derivative of KPU-406 as a chemical probe.
From now on, through determination of the interaction between obtained derivatives and γ-tubulin, it is expected that the function of γ-tubulin is elucidated, leading to the new anticancer drug development.
|
| Free Research Field |
創薬化学
|
